接受输血后送军事医疗机构的严重创伤患者离子钙水平
该研究回顾了2010年1月至2014年12月在阿富汗由英国医疗应急响应小组运送、院前接受血制品的297例创伤患者。比较院前未补钙(237例)与同时接受10%氯化钙10 mL静脉注射(60例)两组入院时离子钙水平。非治疗组低钙血症发生率为70.0%(166例),治疗组为28.3%(17例);血清钙分别为1.03 mmol/L与1.25 mmol/L,差值0.22 mmol/L(95%CI 0.15至0.27)。作者认为输血创伤患者低钙血症风险高,输血期间可能需要积极静脉补钙。
要点
- 院前接受血制品的严重创伤患者中,未补钙组入院低钙血症发生率为70.0%(166/237),补钙组为28.3%(17/60)。
- 补钙组入院血清离子钙为1.25 mmol/L,未补钙组为1.03 mmol/L,差值0.22 mmol/L(95%CI 0.15至0.27)。
- 未补钙组26.6%(63/237)入院钙水平在正常范围,补钙组为41.7%(25/60)。
- 钙水平随血制品输注量增加而显著下降,呈剂量反应关系。
- 作者认为,此类患者低钙血症风险高,输血期间可能需要积极静脉补钙。
适用人群与场景
- 2010年1月至2014年12月在阿富汗由英国医疗应急响应小组运送、院前接受血制品的创伤患者,共297例。
- 非治疗组237例未接受院前静脉补钙,治疗组60例在输注血制品同时接受10%氯化钙10 mL静脉注射。
处置流程与药物剂量
- 治疗组在输注血制品同时接受10%氯化钙10 mL静脉注射;非治疗组未接受院前静脉补钙。
研究设计与关键结果
- 回顾性研究纳入297例院前接受血制品的创伤患者,非治疗组237例,治疗组60例。
- 非治疗组低钙血症发生率为70.0%(166/237),治疗组为28.3%(17/60)。
- 入院血清离子钙非治疗组为1.03 mmol/L,治疗组为1.25 mmol/L,差值0.22 mmol/L(95%CI 0.15至0.27)。
- 非治疗组26.6%(63/237)钙水平在正常范围,治疗组为41.7%(25/60)。
- 钙水平随血制品输注量增加而显著下降,呈剂量反应关系。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,接受血制品的创伤患者低钙血症风险高,输血期间可能需要积极静脉补钙。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hypocalcaemia is a common metabolic derangement in critically ill patients. Blood transfusion can also contribute to depleted calcium levels. The aims of this study were to identify the incidence of hypocalcaemia in military trauma patients receiving blood products en route to a deployed hospital facility and to determine if intravenous calcium, given during the prehospital phase, has an effect on admission calcium levels.
METHODS: This was a retrospective review of patients transported by the UK Medical Emergency Response Team in Afghanistan between January 2010 and December 2014 who were treated with blood products in the prehospital setting. Total units of blood products administered, basic demographics, Injury Severity Score and trauma type were collected. Ionised serum calcium levels on admission to hospital were compared between those who received blood products without prehospital intravenous calcium supplemental therapy (non-treatment) and patients who were treated with 10 mL of intravenous calcium chloride (10%) concurrently with blood products (treatment).
RESULTS: The study included 297 patients; 237 did not receive calcium and 60 did. The incidence of hypocalcaemia in the non-treatment group was 70.0% (n=166) compared with 28.3% (n=17) in the treatment group. Serum calcium levels were significantly different between the groups (1.03 mmol/L vs 1.25 mmol/L, difference 0.22 mmol/L, 95% CI 0.15 to 0.27). In the non-treatment group, 26.6% (n=63) had calcium levels within the normal range compared with 41.7% (n=25) in those who received calcium. There was a dose response of calcium level to blood products with a significant decrease in calcium levels as the volume of blood products increased.
CONCLUSION: Trauma patients who received blood products were at high risk of hypocalcaemia. Aggressive management of these patients with intravenous calcium during transfusion may be required.
参考来源
- Kyle T, Greaves I, Beynon A, et al. Ionised calcium levels in major trauma patients who received blood en route to a military medical treatment facility. Emerg Med J. 2017. PMID: 29175878. doi:10.1136/emermed-2017-206717
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。